Navigation Links
FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Date:2/4/2011

rican College of Obstetricians and Gynecologists issued a written opinion in October 2008 stating that, "Progesterone supplementation for the prevention of recurrent preterm birth should be offered to women with a singleton pregnancy and a prior spontaneous preterm birth due to spontaneous preterm labor or premature rupture of membranes." Makena is indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.  

"As an obstetrician specializing in high risk pregnancies and a mom of two, I know that every week of pregnancy counts," said Ashley Roman, M.D., MPH, Clinical Assistant Professor, Department of Obstetrics and Gynecology, NYU Langone Medical Center.  "I have confidence in the safety and efficacy profile of Makena to reduce the risk of another preterm birth for women who are eligible for therapy."

Important Safety InformationMakena should not be used in women with any of the following conditions: current or history of thrombosis or thromboembolic disorders; known or suspected breast cancer, other hormone-sensitive cancer, or history of these conditions; undiagnosed abnormal vaginal bleeding unrelated to pregnancy; cholestatic jaundice of pregnancy; liver tumors, benign or malignant, or active liver disease; or uncontrolled hypertension.

Makena should be discontinued if thrombosis or thromboembolism occurs. Consider discontinuing Makena if allergic reactions occur. Women receiving Makena should be monitored if they are prediabetic or diabetic; have conditions that may be affected by fluid retention, such as preeclampsia, epilepsy, cardiac or renal dysfunction; develop hypertension; or have a history of clinical depression. Makena should be discontinued if depression recurs.

Certain pregnancy-related fetal and maternal complications or events were numerically increased in Makena-treated subjects as compared to placebo subjects, including miscar
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. FDA Approves Viibryd to Treat Major Depressive Disorder
2. FDA Approves Head Lice Treatment for Children and Adults
3. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
4. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
5. FDA Approves New Dosage Strength for INTELENCE®
6. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
7. FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
8. FDA Approves New Manufacturing Facility for Collagenase SANTYL® Ointment
9. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
10. FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury
11. FDA Approves New Treatment Option for Late-Stage Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... YORK and LONDON , ... of market intelligence, MarketResearch.com is pleased to announce the ... and Consultancy focusing on the active pharmaceutical ingredient (API) ... visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In IQ4I,s ... – Forecast to 2020 , IQ4I ...
(Date:11/26/2014)... YORK , Nov. 25, 2014  Medtronic,s ... Covidien has been widely discussed in the ... it,s also creating a stronger leading player in ... to Kalorama Information.  The healthcare market research firm ... systems will feature a diverse set of solutions ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... , WILMINGTON, Del., Oct. 16 AstraZeneca ... and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) ... familial hypercholesterolemia (HeFH) when diet therapy fails to reduce ... characterized by high LDL cholesterol (the "bad" cholesterol) and ...
... CITY, Oct. 15 Dynatronics Corporation (Nasdaq: DYNT ) ... a letter from Nasdaq stating that the Company has not ... from Nasdaq. , Nasdaq provides the Company an opportunity to ... panel is authorized to grant up to 180 additional calendar ...
Cached Medicine Technology:U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 2U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 3U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia 4
(Date:11/26/2014)... The family foundation of Best Buy founder, ... Research Foundation (Meso Foundation), half of which will be ... Grant Program . The focus area of the Richard ... with organizations that can generate transformational results in education, ... founder and chairman emeritus of Best Buy Co., Inc., ...
(Date:11/26/2014)... German scientists say carbon-based synthetic molecules used in ... looks and acts similar to asbestos-induced mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Medicine in Hannover injected 500 lab rats with multi-walled ... developed mesothelioma , how quickly it developed appeared ...
(Date:11/26/2014)... Los Angeles, CA (PRWEB) November 26, 2014 ... Los Angeles orthopedic surgeon Dr. Steven Meier has ... site to offer current and prospective patients an online ... , “We’re really excited to present the new and ... and added features make it easier than ever for ...
(Date:11/26/2014)... 2014 ISI Telemanagement Solutions, Inc., ... been award the 2014 Lync Pioneer Award ... comes as a great honor to ISI, who ... ecosystem. Specifically, ISI offers an integrated collaboration reporting ... communication, including voice, video, Lync IM, and conferencing. ...
(Date:11/26/2014)... 26, 2014 For those with a New ... LES MILLS BODYPUMP™ classes at the University of Colorado ... they've been looking for. The 45- 60 minute classes have ... and Wellness Center fitness club memberships. , LES MILLS BODYPUMP™ ... fast-paced and are aimed at fast results , By ...
Breaking Medicine News(10 mins):Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 2Health News:Best Buy Founder’s Family Foundation Donates $100,000 to Organization Fighting Deadly Cancer 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2
... found that primitive immune systems of fruit flies may ... that immune memory was not possible for insects. ... Medicine could have implications for new ways of developing ... ,The evidence that a fruit fly's immune ...
... Human embryonic stem cells (hESCs) hold great promise for ... provide evidence// that stem cell-derived nerve cells may integrate ... ,This study was conducted by an international collaboration led ... a member of his lab, Jean-Pyo Lee, Ph.D., of ...
... TVs contain possibly hazardous chemicals called polybrominated diphenyl ethers ... of Standards and Technology and the Environmental Protection Agency ... not yet clear how dangerous these PBDEs are, though ... Their structure is strikingly similar to that of PCBs, ...
... risk of prostate cancer amongst Japanese men by as much ... ,"To our knowledge, this is the first prospective study to ... in Japanese, whose intake of soy food is high," wrote ... ,Over half a million news cases of prostate cancer ...
... team of scientists who have achieved a major breakthrough in ... cancer// tumors in humans. ,Anindya Bagchi, along with ... (CSHL), a private research institute in Long Island, New York, ... cells to misbehave and tumors to form. ,The ...
... Unprocessed cocoa is reported to have huge health benefits ... anesthesia//. This was disclosed by Norman Hollenberg, professor of ... suggests that Epicatechin which is found in high levels ... four major and common diseases of the western world ...
Cached Medicine News:Health News:Flies too Have Immune Memory! 2Health News:Flies too Have Immune Memory! 3Health News:Stem Cells Hold Promise for Treating Neurodegenerative Diseases 2Health News:Stem Cells Hold Promise for Treating Neurodegenerative Diseases 3Health News:Stem Cells Hold Promise for Treating Neurodegenerative Diseases 4Health News:Stem Cells Hold Promise for Treating Neurodegenerative Diseases 5Health News:Soy Isoflavones Linked to Lower Prostate Cancer Risk 2
Nitinol Tipless Stone Basket...
1.5 Fr Nitinol Tipless Stone Basket...
Rapid latex agglutination test for presumptive identification of E. coli serogroup O157:H7 isolates. Colorimetric with red O157 latex and blue H7 latex....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
Medicine Products: